Host: Deanna Minich, PhD, CNS, FACN, IFMCP
Guest: Mark Houston, MD, MS, FAHA, FASH, DABC
Drs. Mark Houston and Deanna Minich delve into the science and proper clinical use of omega-3 fatty acids for the prevention and treatment of heart-related conditions. Dr. Houston vets the methodology and validity of 3 major meta-analyses related to omega-3s and heart health outcomes,1-3 helping to demystify the seemingly complex science and conflicting conclusions, so you can understand the data. Drs. Houston and Minich also discuss food consumption, targeted supplementation, and key biomarkers that support the clinical implementation of science on omega-3s and other heart health-pertinent nutritional bioactives.
This Metagenics Institute LIVE broadcast took place live August 21, 2018 on the Metagenics Institute Facebook page.
Citations
- Alexander DD, Miller PE, Van Elswyk ME, Kuratko CN, Bylsma LC. A meta-analysis of randomized controlled trials and prospective cohort studies of eicosapentaenoic and docosahexaenoic long-chain omega-3 fatty acids and coronary heart disease risk. Mayo Clin Proc. 2017;92(1):15-29.
- Aung T, Halsey J, Kromhout D, et al. Associations of omega-3 fatty acid supplement use with cardiovascular disease risks: meta-analysis of 10 trials involving 77,917 individuals. JAMA Cardiol. 2018;3(3):225-234.
- Abdelhamid AS, Brown TJ, Brainard JS, et al. Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease. Cochrane Database of Systematic Reviews. 2018;7:CD003177.
